共 14 条
[1]
Bay JO,Chonfi B,Pomel C,et al.Potential allogeneic graftversustumor effect in a patient with ovarian cancer. Bone Marrow Transplantation . 2000
[2]
Alyea EP,Soiffer RJ,Canning C,et al.Toxicity and effecacy of defined dose of D4+ donor lymphocytes for treatment of relaps after alloyeneic bone marrow transplant. Blood . 1998
[3]
Verdonck LF,Petersen EJ,Lokhorst HM,et al.Donor leukocyte infusion for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cell. Bone Marrow Transplantation . 1998
[4]
Pan L,Demonte J,Jalonen CK,et al.Pretreatrment of donor mice with granulocyte colony-stimulating factor polarized donor T lymphocytes toward type-2 cytokine production and reduces severity of expermental graft -versus-host disease. Blood . 1995
[5]
Childs R,Chernoff A,Contentin N,et al.Regression of metastastic renal -cell carcinoma after nonmyeloablative allogeneic peripheral -blood stem-cell transplantation. The New England Journal of Medicine . 2000
[6]
Teshima T,Hill GR,Pan L,et al.IL-11 seperafes graft -versusleukemia effect from graft -verus-host disease after bone marrow transplantation. The Journal of Clinical Investigation . 1999
[7]
Blazar BR,Taylor PA,Panoskaltsis-Mortari A,et al.Rapamycin inhibits the generation of graft -versus-host disease and graft versus-leukemia of Th1 or Th1 cytotoxic cytokines. J Immunol . 1998
[8]
Snowde JA,Nivison-Smith I,Atkinson K,et al.Allogeneic PBPC transplantation: an effect on incidence and distribution of chronic graft -versus-host disease without long-term survial benefit. Bone Marrow Transplantation . 2000
[9]
Bonini C,Ferrari G,Verzeletti S,et al.HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft -versus-leukemia. Science . 1997
[10]
Kummar S. Lsbii A,Yang HK,et al.Modulation of graft -versustumor effects in a murine allogeneis bone marrow transplantation model by tumor-derived transforming growth factor- 1. Biology of Blood and Marrow Transplantation . 2001